Acute myocardial infarction (MI) indicates irreversible myocardial injury resulting in necrosis of a significant portion of myocardium (generally >1 cm). The term "acute" denotes infarction less than 3-5 days old, when the inflammatory infiltrate is primarily neutrophilic. Acute MI may be either of the nonreperfusion type, in which case the obstruction to blood flow is permanent, or of the reperfusion type, in which the obstruction or lack of blood flow is long enough in duration (generally hours) but is reversed or restored after myocardial cell death occurs.
Acute myocardial infarction (MI) generally refers to segmental (regional) myocardial necrosis, typically endocardium-based, secondary to occlusion of an epicardial artery. In contrast, concentric subendocardial necrosis may result from global ischemia and reperfusion in cases of prolonged cardiac arrest with resuscitation. Areas of myocardial infarction may be subepicardial if there is occlusion of smaller vessels by thromboemboli originating from coronary thrombi. In the majority of patients, there is obstructive coronary disease at angiography.
The area of infarct occurs in the distribution of the occluded vessel. Left main coronary artery occlusion generally results in a large anterolateral infarct, whereas occlusion of the left anterior descending coronary artery causes necrosis limited to the anterior wall. There is often extension to the anterior portion of the ventricular septum with proximal left coronary occlusions.
In hearts with a right coronary dominance (with the right artery supplying the posterior descending branch), a right coronary artery occlusion causes a posterior (inferior) infarct. With a left coronary dominance (about 15% of the population), a proximal circumflex occlusion will infarct the posterior wall; in the right dominant pattern, a proximal obtuse marginal thrombus will cause a lateral wall infarct only, and the distal circumflex is a small vessel.
The anatomic variation due to microscopic collateral circulation, which is not evident at autopsy, plays a large factor in the size of necrosis and distribution. Unusual patterns of supply to the posterior wall, such as wraparound left anterior descending or posterior descending artery supplied by the obtuse marginal artery, may also result in unexpected areas of infarct in relation to the occluded proximal segment.
A proximal occlusion at the level of an epicardial artery results in a typical distribution that starts at the subendocardium and progresses towards the epicardium (the so-called wavefront phenomenon).  Therefore, an area of necrosis or scarring is considered to have an "ischemic pattern" if it is largest at the endocardium, with a wedge-shaped extension up to the epicardial surface.
Ischemic injury, however, may be located in the mid myocardium or even the subepicardium if the level of the coronary occlusion is distal within the myocardium. Therefore, in cases of thromboemboli from epicardial thrombi (especially plaque erosions), there may be patchy infarction, often associated with visible thrombi within the myocardial vessels, not centered in the endocardium but occurring anywhere in the myocardium, including midepicardial and subepicardial locations.
Acute myocardial infarction (MI) results from lack of oxygen supply to the working myocardium. Regional infarcts are due to lack of blood flow that occurs when an epicardial artery is blocked by atheroma or thrombus, or other obstructions. Global subendocardial infarcts occur when there is lack of oxygenation despite circulation—for example, when there is a respiratory arrest followed by prolonged hypoxemia.
Autopsies of hospital inpatients dying of acute regional MI reveal an acute thrombus overlying atherosclerotic plaque in more than 95% of cases when the coronary arteries are carefully inspected.  In the remaining hearts, there will be severe coronary diseases without thrombus.
Rare causes of acute MI include no apparent cause (usually attributed to coronary spasm), coronary embolism (varied causes, including valve vegetations and tumors), spontaneous coronary artery dissections, congenital anomalies of the coronary origins, and thrombosis in nonatherosclerotic normal coronary arteries (hypercoagulable states).
There is a known genetic predisposition to coronary artery disease that leads to acute MI. In general, about 50-85% of the risk of coronary atherosclerosis is secondary to acquired conditions. The remainder is secondary to genetic polymorphisms, which involve pathways of inflammation, lipid metabolism, coagulation, the renin-angiotensin-aldosterone system, and other components of atherogenesis. [3, 4]
Acute myocardial infarctions (MIs) are common. In the United States, they result in the hospitalization of approximately 4 men and 2 women per 1000 population each year. 
The symptoms of acute myocardial infarction (MI) are chest pain, which may radiate to the arm or jaw, sweating, nausea, and chest tightness or pressure. The diagnosis rests on laboratory findings of myocardial necrosis, which causes leakage of myocardial enzymes, such as troponin, into the circulating blood. Acute infarcts are divided by electrocardiographic findings into ST-elevation myocardial infarction (STEMI) and non ST-elevation infarction (non-STEMI).
A prospective cohort study of 6304 consecutively enrolled patients with suspected acute coronary syndrome reported that in patients without myocardial infarction at presentation, troponin concentrations were less than 5 ng/L in 2311 (61%) of 3799 patients, with a negative predictive value of 99·6% for the primary outcome. The study concluded that low plasma troponin concentrations identified two-thirds of patients who were at very low risk of cardiac events and who could be discharged from the hospital. 
STEMI is usually the result of blockage of a coronary artery with large elevations of cardiac enzymes in the serum and eventually result in Q waves on the electrocardiogram. In contrast, non-STEMI, which overlaps with the acute coronary syndrome unstable angina, causes modest elevations of cardiac enzymes in the serum and pathologically shows small or patchy areas of necrosis. Q waves do not develop in non-STEMI.
The earliest change that can be grossly discerned in the evolution of acute myocardial infarction (MI) is pallor of the myocardium, which is visible 12 hours or later after the onset of irreversible ischemia. The gross detection of infarction can be enhanced by the use of tetrazolium salt solutions, which form a colored precipitate on gross section of fresh heart tissue in the presence of dehydrogenase-mediated activity. Myocardial necrosis can be detected as early as 2-3 hours in dogs and in humans by this method.
In nonreperfused MI, the infarcted area is well defined at 2-3 days, with a central area of yellow discoloration surrounded by a thin rim of highly vascularized hyperemia (see the first image below). In reperfused MI, the infarcted region appears red because of trapping of the red cells and hemorrhage from ruptured necrotic capillaries (see the second image below).
At 5-7 days, the regions are much more distinct, with a central soft area and a depressed hyperemic border. At 1-2 weeks, the infarct begins to appear depressed, especially at the margins where organization takes place, and the borders take on a white hue.
Healing may be complete as early as 4-6 weeks for small infarcts or may take as long as 2-3 months for large ones (see the images below). Areas of congestion and vasodilatation within healed scars may appear hemorrhagic. In these cases, mottled myocardium that gives the gross appearance of acute MI may, upon histologic examination, demonstrate only old fibrosis.
Healed infarcts are white from the scarring, and the ventricular wall may be thinned (aneurysmal), especially in transmural infarction (see the image below). In general, infarcts that occupy more than 50% of the ventricular wall, from the subendocardial to the epicardial surface, are considered transmural and are associated with Q-wave changes on electrocardiography.
Microscopically, the diagnosis of acute myocardial infarction (MI) rests on the presence of necrotic myocardium, with an interface of acute inflammation separating it from viable myocardium. Areas of inflammation with a scar or areas of mummified dead myocardium bordered by granulation tissue do not indicate the presence of acute MI.
The earliest morphologic characteristic of MI occurs between 12 and 24 hours after the onset of chest pain. Hypereosinophilia of the cytoplasm as assessed by hematoxylin-eosin staining is characteristic of myocardial ischemia (see the first image below). Neutrophil infiltration is present by 24 hours at the border areas (see the second image below).
As the infarct progresses between 24 and 48 hours, coagulation necrosis is established, with various degrees of nuclear pyknosis, early karyorrhexis, and karyolysis. The myocyte striations are preserved and the sarcomeres elongate. The border areas show prominent neutrophil infiltration by 48 hours.
At 3-5 days, the central portion of the infarct shows loss of myocyte nuclei and striations; in smaller infarcts, neutrophils invade the infarct and fragment, resulting in more severe karyorrhexis (nuclear dust). By 5-7 days, macrophages and fibroblasts begin to appear in the border areas. By 1 week, neutrophils decline and granulation tissue is established (see the image below), with neocapillary invasion and lymphocytic and plasma cell infiltration.
Although lymphocytes may be seen as early as 2-3 days, they are not prominent in any stage of infarct evolution. Eosinophils may be seen within the inflammatory infiltrate but are present in only 24% of infarcts. There is phagocytic removal of the necrotic myocytes by macrophages, and pigment is seen within macrophages. 
By the second week, fibroblasts are prominent, but they may appear as early as 1 week at the periphery of the infarct (see the image below). There is continued removal of the necrotic myocytes as the fibroblasts are actively producing collagen, and angiogenesis occurs in the area of healing.
Healing continues and, depending on the extent of necrosis, may be complete as early as 4 weeks or may require 8 weeks or longer to complete (see the image below). The central area of large infarction may remain unhealed and show mummified myocytes for extended periods, even though the infarct borders are completely healed.
The histologic dating of MI may be important from a medicolegal point of view. There is no way of determining infarct age exactly, however, both because the histologic features that define the stages of repair overlap and because infarcts may enlarge, resulting in heterogeneity from one area to another. The border zone between necrotic myocardium and viable myocardium is the focus of dating, which depends on the reaction of viable myocardium to the area of infarct.
At 24 hours of occlusion followed by reperfusion after 6 hours in a canine model, myocytes are thin, hypereosinophilic, and devoid of nuclei or showing karyorrhexis, with ill-defined borders and interspersed areas of interstitial hemorrhage. There is a diffuse but mild neutrophil infiltration. Within 2-3 days, macrophage infiltration is obvious and there is phagocytosis of necrotic myocytes and early stages of granulation tissue.
Infarct healing is more rapid in dogs than in humans, most likely because of nondiseased adjoining coronary arteries (collaterals) and a lack of underlying myocardial disease. In humans with acute MI, there is often chronic ischemia secondary to extensive atherosclerotic disease.
In humans, if reperfusion occurs within 4-6 hours after the onset of chest pain or electrocardiographic (ECG) changes, there is myocardial salvage, and the infarct is likely to be subendocardial without transmural extension. There will be a nearly confluent area of hemorrhage within the infarcted myocardium, with extensive contraction band necrosis. Within a few hours of reperfusion, sparse neutrophils are evident within the area of necrosis, but they are usually sparse.
Macrophages begin to appear by day 2-3; by day 3-5, fibroblasts appear, with an accelerated rate of healing as compared with that of nonreperfused infarcts. Subendocardial infarcts may be fully healed as early as 2-3 weeks. Larger infarcts and those reperfused after 6 hours take longer to heal. Infarcts reperfused after 6 hours show larger areas of hemorrhage than do occlusions with more immediate reperfusion.
Immunohistochemistry is of limited use in the diagnosis of acute myocardial infarction (MI). Immunolocalization of complement or fibrin may be helpful in identifying areas of myocyte necrosis, where there is leakage of extracellular proteins into the myocytes. In addition, markers of ischemia include hypoxia-inducible factor-1, complement leaking into myocytes, and cyclooxygenase-2, which can be demonstrated immunohistochemically.
Prognosis and Predictive Factors
The morbidity and mortality of myocardial infarction (MI) result from arrhythmias, cardiac rupture, heart failure, valve insufficiency, and embolization.
Arrhythmias include ventricular tachyarrhythmias, which are the most common cause of sudden death, especially early after infarction, and various degrees of heart block.
Cardiac rupture occurs in approximately 5% of patients, has a high mortality, and is increased in frequency in patients experiencing their first infarct, hypertensive patients, and women. 
The risk of heart failure is proportional to the size of the infarct and the presence of papillary muscle necrosis. The size of infarct may be significantly decreased with prompt reperfusion after the first symptoms, either by thrombolytic treatment or by percutaneous intervention. Stem cell treatment is an investigative approach to minimizing myocardial infarct size.
Infarction or rupture of the posteromedial papillary muscle causes acute mitral insufficiency, which greatly worsens cardiac output and which may be treated surgically. The improvement in prognosis that has occurred in the last decade is due to early treatment with thrombolytic agents and reperfusion. 
Mural thrombosis over the area of infarction may result in embolization and concomitant stroke but is decreased in incidence with anticoagulation therapy.